Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
Objectives: Ceftobiprole is an advanced-generation cephalosporin with a favourable safety profile. Published data on the clinical use of ceftobiprole are limited. We report use of ceftobiprole in Canadian patients using data captured by the CLEAR registry. Methods: The CLEAR registry uses the web-ba...
Main Authors: | George G. Zhanel, Justin Kosar, Melanie Baxter, Rita Dhami, Sergio Borgia, Neal Irfan, Kelly S. MacDonald, Gordon Dow, Philippe Lagacé-Wiens, Maxime Dube, Marco Bergevin, Carlo Tascini, Yoav Keynan, Andrew Walkty, James Karlowsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221371652100028X |
Similar Items
-
Real-life experience with ceftobiprole in a tertiary-care hospital
by: Emanuele Durante-Mangoni, et al.
Published: (2020-09-01) -
Ceftobiprole for the treatment of infective endocarditis: A case series
by: Carlo Tascini, et al.
Published: (2020-03-01) -
Ceftobiprole Perspective: Current and Potential Future Indications
by: Tommaso Lupia, et al.
Published: (2021-02-01) -
Surveillance of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2018 from different European territories
by: Stephen Hawser, et al.
Published: (2021-09-01) -
In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)